HEALTH & LIFE SCIENCES NEWS
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries

Avatar McDermott Will & Emery

Subscribe to McDermott Will & Emery's Posts

European Healthcare Innovation & Investment in a Post-Pandemic World


By on Jul 6, 2020
Posted In Digital Health, Health M&A, Health Private Equity, Hospitals & Health Systems, International Health

As part of McDermott’s HPE Europe 2020: Where Do the Opportunities Exist for Investment in the Healthcare Sector? webinar, McDermott London Managing Partner Hamid Yunis moderated a panel of industry experts including; Dr. Michelle Tempest of Candesic, Dr. Joanne Hackett of IZY Capital, Dr. Charles Niehaus and Professor Karol Sikora of Rutherford Cancer Centres, who...

Continue Reading



Unpacking Differences in Public and Private Hospital M&A


By on Jun 15, 2020
Posted In Health M&A, Hospitals & Health Systems, Tax-Exempt

Across the public hospital sector, M&A activity has increased significantly over the past decade. Given the current COVID-19 landscape, many are taking a hard look at their operations to garner a better understanding of what needs to be done to be regain level footing during a tough financial time, while also focusing on a need...

Continue Reading



More Than a Decade at the Top; McDermott Earns 11th Chambers USA Band 1 Healthcare Practice National Ranking


By on May 6, 2020
Posted In Uncategorized

We are pleased to announce that our Healthcare Group received a national Band 1 ranking for the eleventh year in a row in the 2020 edition of Chambers USA. After more than a decade at the top, we are once again the only one to rank Band 1 nationally. The Health team also earned Band...

Continue Reading



Top Takeaways: Critical Business Considerations for Life Sciences and Medical Device Companies During COVID-19


By on May 5, 2020
Posted In FDA, Life Sciences

Life sciences and medical device companies are dealing with an unprecedented crisis. The industry is not only managing the impact of Coronavirus (COVID-19), they are also a solution provider. Companies are rapidly adapting products, services, facilities and distribution channels to aid in the pandemic response. Simultaneously, they must maintain shareholder value, navigate highly complex regulatory...

Continue Reading



Coronavirus Resource Center | Preparedness Planning for Businesses


By on Mar 5, 2020
Posted In Digital Health, Hospitals & Health Systems, International Health

In our global economy, Coronavirus (COVID-19) raises serious concerns for employers in all industries. Workers may be on the front lines caring for patients and developing vaccines, travelling for business, or in close contact with individuals who travel or may have been affected. At this time, there is no vaccine or medication approved to prevent...

Continue Reading



Five Questions with a Health Lawyer: Nicholas Alarif


By on Feb 28, 2020
Posted In Fraud & Abuse

Nicholas Alarif Office: Washington, DC Years at Firm:  3 What is your favorite part about practicing healthcare law at McDermott?  I hate to sound like a broken record, but the best part about practicing at McDermott is the innovative and collaborative culture. I have found that McDermott fosters a team-based approach to solving client issues....

Continue Reading



Five Questions with a Health Lawyer: Matt Perreault


By on Feb 14, 2020
Posted In Hospitals & Health Systems, Uncategorized

Matt Perreault Office: Boston Years at Firm:  2 What is your favorite part about practicing health care law at McDermott?  As so many of my colleagues have expressed throughout this series, my favorite part of practicing healthcare law at McDermott is being a member of a collaborative and collegial team that is advising our diverse...

Continue Reading



2019 Hospital and Health Systems Year in Review


By on Feb 7, 2020
Posted In Hospitals & Health Systems

Hospitals and health systems are facing consumer demand for innovation, the need to expand and enhance streams of revenue and the push for improved quality, all while navigating changing regulations, federal enforcement, antitrust litigation and business pressures. 2019 saw hospitals and health systems navigate these challenges and more, with valuable lessons for 2020. This Special Report presents...

Continue Reading



Five Questions with a Health Lawyer: Joe Parise


By on Jan 27, 2020
Posted In Health M&A

Joe Parise Partner Office: Boston Years at Firm: 6 What is your favorite part about practicing healthcare law at McDermott?  In short: the people. I have always had a cross-office practice, and as a result have been lucky enough to work with many different attorneys within the Health practice group. I am constantly impressed by...

Continue Reading



Five Questions with a Health Lawyer: Larry Guess


By on Jan 17, 2020
Posted In Health M&A, Health Private Equity

Larry Guess Partner Office: Chicago Years at the Firm: 6 years What is your favorite part about practicing healthcare law at McDermott?  My favorite part of practicing healthcare law at McDermott is the complexity of our client matters and working with my colleagues to get great results for our clients. The healthcare industry is constantly...

Continue Reading



STAY CONNECTED

TOPICS

ARCHIVES